Stay updated on PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial
Sign up to get notified when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.

Latest updates to the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes the addition of 'HER2-positive Solid Tumor' and the collaborators, while significant details about the study's design and eligibility criteria have been removed.SummaryDifference13%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.